In 1993, I reached another crossroads. I had established various BCR-ABL–driven model systems and had even written a grant with Jim Griffin outlining how to characterize BCR-ABL kinase inhibitors.

For more than a century, Parsons has been inspired by the transformative potential of design. Today, the school’s groundbreaking academic programs carry forward that mission, making Parsons the number ...